Young Mok Lee Selected Research

Glycogen Storage Disease IB

4/2022	Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib.
1/2020	Glucose-6-phosphate transporter mediates macrophage proliferation and functions by regulating glycolysis and mitochondrial respiration.
1/2020	Glycogen storage disease type Ib: role of glucose-6-phosphate transporter in cell metabolism and function.
1/2018	Aberrant proliferation and differentiation of glycogen storage disease type Ib mesenchymal stem cells.
11/2017	Liver-directed gene therapy for murine glycogen storage disease type Ib.
1/2017	Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration.
5/2014	Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young Mok Lee Research Topics

Disease

8	Neutropenia 04/2022 - 10/2010
8	Hepatorenal form of glycogen storage disease 12/2021 - 06/2010
7	Glycogen Storage Disease IB 04/2022 - 05/2014
7	Glycogen Storage Disease (Glycogenosis) 04/2022 - 05/2014
7	Asthma (Bronchial Asthma) 01/2010 - 12/2002
6	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2021 - 11/2012
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
3	Hepatomegaly 01/2021 - 11/2013
3	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 11/2013
3	Neoplasms (Cancer) 01/2020 - 11/2017
3	Obesity 11/2017 - 09/2015
3	Insulin Resistance 11/2017 - 09/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2020
2	Inflammation (Inflammations) 11/2019 - 08/2003
2	Seizures (Absence Seizure) 06/2015 - 08/2006
1	Kidney Diseases (Kidney Disease) 12/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Carcinogenesis 01/2020
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 11/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2019
1	Hypoxia (Hypoxemia) 05/2014
1	Hyperlipidemias (Hyperlipidemia) 11/2013
1	Hyperuricemia 11/2013
1	Autosomal Recessive 3 Severe Congenital Neutropenia 10/2010
1	Hypersensitivity (Allergy) 01/2010
1	Bronchial Spasm 01/2010
1	Sinusitis 01/2010
1	Disease Progression 02/2008
1	Landau-Kleffner Syndrome 08/2006
1	Virus Diseases (Viral Diseases) 11/2005
1	Respiratory Hypersensitivity 11/2005
1	Cough 06/2004
1	Eosinophilia 08/2003

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 06/2010
10	Glucose-6-PhosphateIBA 04/2022 - 10/2010
5	EnzymesIBA 12/2021 - 10/2010
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2019
2	Liver GlycogenIBA 01/2021 - 11/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017 - 04/2011
2	CytokinesIBA 01/2004 - 08/2003
2	Immunoglobulin E (IgE)IBA 06/2003 - 12/2002
1	MicroRNAs (MicroRNA)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	GlycogenIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Pyruvate KinaseIBA 01/2020
1	Messenger RNA (mRNA)IBA 11/2019
1	CollagenIBA 11/2019
1	Phosphorylases (Glucan Phosphorylase)IBA 11/2019
1	Ketone BodiesIBA 11/2019
1	LigandsIBA 11/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2019
1	Chemokine CCL5IBA 11/2019
1	CC ChemokinesIBA 11/2019
1	Carrier Proteins (Binding Protein)IBA 11/2017
1	CarbohydratesIBA 11/2017
1	IntegrinsIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2015
1	Peroxisome ProliferatorsIBA 05/2014
1	phosphatidylinositol 3,4,5-triphosphateIBA 04/2011
1	Caspase 3 (Caspase-3)IBA 04/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2010
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2010
1	montelukast (Singulair)FDA Link 01/2010
1	Methylprednisolone FDA LinkGeneric 02/2008
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2006
1	Carnitine (L-Carnitine)FDA LinkGeneric 08/2006
1	Riboflavin (Vitamin B2)FDA LinkGeneric 08/2006
1	coenzyme Q10 (CoQ10)IBA 08/2006
1	Anticonvulsants (Antiepileptic Drugs)IBA 08/2006
1	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2006
1	AllergensIBA 11/2005
1	Fluticasone (Cutivate)FDA LinkGeneric 09/2005
1	GlucocorticoidsIBA 09/2005
1	Methacholine Chloride (Methacholine)FDA Link 06/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2004
1	Interleukin-3 (Interleukin 3)IBA 01/2004
1	Interleukin-10 (Interleukin 10)IBA 01/2004
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2004
1	Interleukin-4 (Interleukin 4)IBA 01/2004
1	Interleukin-2 (IL2)IBA 01/2004
1	Interleukin-8 (Interleukin 8)IBA 01/2004
1	SteroidsIBA 08/2003
1	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 08/2003
1	Interleukin-5 (Interleukin 5)IBA 08/2003
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 12/2002
1	AntibodiesIBA 12/2002
1	Immunoglobulin G (IgG)IBA 12/2002
1	Human Serum Albumin FDA LinkGeneric 12/2002

Therapy/Procedure

4	Therapeutics 01/2017 - 09/2005
1	Ketogenic Diet 08/2006